Completed PHASE4 INTERVENTIONAL 2-arm
NCT00298870
Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
Sponsor: Osaka University
Conditions
Pulmonary Tuberculosis
Updated 1 time since 2024 Last updated: Oct 17, 2012 Started: Jun 30, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Pulmonary Tuberculosis, this trial is completed. The trial is conducted by Osaka University and has accumulated 1 data snapshot since 2005. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Completed — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Osaka University
Data source: Osaka University
For direct contact, visit the study record on ClinicalTrials.gov .